Metastatic Melanoma Therapeutics: Advances in Treatment Options for...

adicionou um novo artigo Health

2024-08-05 11:06:42 - Traduzir -

Metastatic Melanoma Therapeutics: Advances in Treatment Options for Metastatic Melanoma

While ipilimumab was an important first approval, it only helped about 15-20% of patients and many experienced severe side effects. Since then, several other immunotherapies have been approved that have higher response rates and are generally better tolerated. Keytruda (pembrolizumab) was approved in 2014 for metastatic melanoma patients whose cancer had stopped responding to other treatments....

0 Comentários 0 Compartilhamentos 616 Visualizações 0 Anterior